12:00 AM
 | 
Oct 03, 2016
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Swedish Orphan Biovitrum sales and marketing update

France, Italy, Spain and the U.K. approved national reimbursement for hemophilia A drug Elocta efmoroctocog alfa from Swedish Orphan. Swedish Orphan has rights from ...

Read the full 114 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >